[ad_1]
"I have treated more than 3,000 patients since 2006," said Dr. Wilfried Mutombo, coordinator of the DNDi project for sleeping sickness. "If I had had fexinidazole at that time, I would not have had to hospitalize them all and I would have had fewer relapses."
"Most other infectious diseases are treated in pharmacies. I hope this will happen now for sleeping sickness. "
TThe drug has been approved in the DRC through an innovative regulatory mechanism to accelerate the approval of new drugs outside the European Union. Uganda is expected to present a similar communication later this year.
Dr. Nathalie Strub-Wourgaft, director of neglected tropical diseases at DNDi, said the rapid approval since the decision of the European Medicines Agency in November was important.
"We are looking forward to implementing fexinidazole as a first-line treatment and we welcome this rapid approval of fexinidazole in the DRC," she said.[It is] demonstrates the determination of the DRC government, through the Ministry of Health, to eliminate [sleeping sickness] as a public health problem by 2020. "
[ad_2]
Source link
